Clinical Trials Logo

Enterocolitis, Pseudomembranous clinical trials

View clinical trials related to Enterocolitis, Pseudomembranous.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05077085 Withdrawn - Clinical trials for Clostridium Infections

Bezlotoxumab Versus FMT for Multiple Recurrent CDI

BSTEP
Start date: January 2022
Phase: Phase 4
Study type: Interventional

The objective of this trial is to investigate whether a treatment strategy offering bezlotoxumab before FMT in patients suffering from multiple recurrent CDI results in equal efficacy compared with a treatment strategy with initial FMT. Strategy A includes bezlotoxumab as ancillary treatment as first option, and FMT in case of failure. Option B includes FMT as ancillary treatment as first option, and antibiotic treatment with fidaxomicin in case of failure. A secondary objective is to provide a point estimate of recurrence after bezlotoxumab for the treatment of multiple recurrent CDI.

NCT ID: NCT00304863 Withdrawn - Clinical trials for Pseudomembranous Colitis

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Start date: August 1, 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether dietary supplementation with Lactobacillus GG will reduce the rate of failure or relapse following treatment of CDAD with metronidazole.